Page last updated: 2024-08-24

pemirolast and paclitaxel

pemirolast has been researched along with paclitaxel in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goromaru, T; Hirakawa, T; Itoh, Y; Nakano, H; Oishi, R; Sendo, T; Takasaki, S1
Hirakawa, T; Itoh, Y; Nakano, H; Oishi, R; Saito, M; Sendo, T; Uchida, M; Yahata, H1
Egashira, N; Kawashiri, T; Oishi, R; Yano, T1

Trials

1 trial(s) available for pemirolast and paclitaxel

ArticleYear
Prophylactic effect of pemirolast, an antiallergic agent, against hypersensitivity reactions to paclitaxel in patients with ovarian cancer.
    International journal of cancer, 2006, May-15, Volume: 118, Issue:10

    Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Ovarian Neoplasms; Paclitaxel; Placebos; Pyridines; Pyrimidinones

2006

Other Studies

2 other study(ies) available for pemirolast and paclitaxel

ArticleYear
Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats.
    Neuropharmacology, 2004, Volume: 46, Issue:6

    Topics: Animals; Calcitonin Gene-Related Peptide; Dose-Response Relationship, Drug; Drug Hypersensitivity; Male; Neurokinin A; Neuropeptides; Paclitaxel; Pyridines; Pyrimidinones; Rats; Rats, Sprague-Dawley; Substance P

2004
[Substance P in antitumor drug-induced adverse reactions].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2013, Volume: 142, Issue:5

    Topics: Animals; Antineoplastic Agents; Carboplatin; Histamine Antagonists; Humans; Nausea; Neuropeptides; Paclitaxel; Pyridines; Pyrimidinones; Substance P; Vomiting

2013